Cautionary Notes Regarding Forward-Looking Statements
Certain information contained on this website, as well as in other public filings, the company web site, press releases and oral statements made by our representatives, is forward-looking information based on current expectations and plans that involve risks and uncertainties. Forward-looking information includes statements concerning pharmacy sales trends, prescription margins, number of new store openings, and the level of capital expenditures, demographic trends; as well as those that include or are preceded by the words "expects," "estimates," "believes," "plans," "anticipates" or similar language. For such statements, we claim the protection of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
The following factors, in addition to those discussed elsewhere in our Form 10-Qs and our Annual Report on Form 10-K for the fiscal year ended August 31, 2003, could cause results to differ materially from management expectations as projected in such forward-looking statements: the impact of events related to any terrorist actions, changes in economic conditions generally or in the markets served by the company; consumer preferences and spending patterns; competition from other drugstore chains, supermarkets, on-line retailers, other retailers and mail order companies; the introduction of new brand and generic prescription drugs; changes in state or federal legislation or regulations; the efforts of third party payers to reduce prescription reimbursement rates; the success of planned advertising and merchandising strategies; the availability and cost of real estate and construction; changes in accounting policies and practices; the company's ability to hire and retain pharmacists and other store and management personnel; the company's relationships with its suppliers; the company's ability to successfully implement new computer systems and technology; and adverse determinations with respect to litigation or other claims. Unless otherwise required by applicable securities laws, Walgreens assumes no obligation to update its forward-looking statements to reflect subsequent events or circumstances. Other risks or uncertainties may be periodically detailed in future Securities and Exchange Commission (SEC) filings.
WAG Stock Price
2:16 PM ET Mar 18, 2010
$34.77 (
$0.29)
Day High
Day Low
52-week High
52-week Low
$34.77
$34.41
$40.69
$23.62
Trend Report
Walgreens Health Initiatives 2009 Prescription Drug Trend Report. Download the full report online today!
